IRIS
SEDDAIU, Maria Antonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.514
AS - Asia 1.450
EU - Europa 993
SA - Sud America 860
AF - Africa 48
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.439
BR - Brasile 777
SG - Singapore 605
CN - Cina 472
UA - Ucraina 317
DE - Germania 152
SE - Svezia 114
HK - Hong Kong 93
IT - Italia 88
GB - Regno Unito 68
FI - Finlandia 66
VN - Vietnam 56
TR - Turchia 53
FR - Francia 49
CZ - Repubblica Ceca 41
CA - Canada 35
AR - Argentina 26
IQ - Iraq 26
BE - Belgio 24
RU - Federazione Russa 24
MX - Messico 23
ID - Indonesia 18
BD - Bangladesh 16
EC - Ecuador 16
IN - India 16
ZA - Sudafrica 16
JP - Giappone 14
VE - Venezuela 14
PL - Polonia 12
UZ - Uzbekistan 11
IR - Iran 10
MA - Marocco 10
JO - Giordania 9
LT - Lituania 9
PY - Paraguay 9
AZ - Azerbaigian 8
CO - Colombia 8
KR - Corea 8
AT - Austria 7
ES - Italia 7
PK - Pakistan 7
AU - Australia 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
NL - Olanda 5
BG - Bulgaria 4
CL - Cile 4
HN - Honduras 4
NP - Nepal 4
PA - Panama 4
TN - Tunisia 4
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
PE - Perù 3
AM - Armenia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IL - Israele 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 5.876
Salva come PNG Salva come JPEG
Città #
Dallas 860
Chandler 370
Singapore 362
Jacksonville 191
Beijing 98
Princeton 96
Hong Kong 93
Nanjing 76
Dearborn 75
Ann Arbor 69
Ashburn 59
Sassari 57
Wilmington 52
São Paulo 49
Brno 38
Rio de Janeiro 38
Nanchang 37
Boardman 34
Shanghai 30
Izmir 27
Munich 26
Woodbridge 26
Changsha 25
Los Angeles 25
Shenyang 25
Brussels 24
Ho Chi Minh City 23
Tianjin 21
Santa Clara 20
The Dalles 16
Belo Horizonte 15
London 15
Zhengzhou 15
Baghdad 14
Brasília 14
Jiaxing 14
Tokyo 14
Toronto 14
Columbus 13
Hebei 13
Helsinki 13
Jinan 13
New York 13
Porto Alegre 13
Council Bluffs 12
Warsaw 12
Campinas 11
Hangzhou 11
Hanoi 11
Nuremberg 11
Tashkent 11
Falls Church 10
Ningbo 10
Amman 9
Augusta 9
Boston 9
Guarulhos 9
Salvador 9
Ardabil 8
Baku 8
Goiânia 8
Johannesburg 8
Leawood 8
Norwalk 8
San Francisco 8
San Mateo 8
Seoul 8
Stockholm 8
Turku 8
Andover 7
Buffalo 7
Frankfurt am Main 7
Guangzhou 7
Guayaquil 7
Istanbul 7
Mexico City 7
Quito 7
Santo André 7
Taizhou 7
Brooklyn 6
Chennai 6
Contagem 6
Curitiba 6
Denver 6
Fortaleza 6
Ipatinga 6
Joinville 6
Kunming 6
Monmouth Junction 6
Mountain View 6
Nairobi 6
Ottawa 6
Praia Grande 6
Ribeirão Preto 6
Aracaju 5
Atlanta 5
Auburn Hills 5
Campo Grande 5
Maceió 5
Mauá 5
Totale 3.557
Salva come PNG Salva come JPEG
Nome #
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 200
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 168
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 165
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 162
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 159
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 158
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 157
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 157
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 151
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 141
Experimental models to define the genetic predisposition to liver cancer 140
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 139
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 139
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 139
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 136
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 135
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 132
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 132
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 131
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 131
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 127
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 125
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 125
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 123
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 122
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 119
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 118
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 117
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 115
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 114
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 114
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 114
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 113
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 112
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 111
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 109
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 105
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 103
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 103
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 99
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 93
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 91
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 83
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 82
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 80
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 79
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 79
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. 45° Annual Meeting of the European Association for the Study of the Liver (EASL) Aprile 14-18, 2010 74
Totale 5.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 21 53 1 67 69 64 14
2021/2022270 44 1 1 5 4 7 20 11 26 22 30 99
2022/2023632 67 64 13 120 51 106 0 69 109 1 19 13
2023/2024162 29 13 1 5 19 3 0 4 0 1 22 65
2024/20251.648 13 20 64 61 77 53 115 314 509 290 92 40
2025/20261.749 134 609 433 299 228 46 0 0 0 0 0 0
Totale 5.921